INSTRUCTIONS FOR CLOMIPHENE CITRATE CHALLENGE TEST (CCCT) AND ANTI-MULLERIAN HORMONE (AMH)
The Clomiphene Citrate Challenge Test (CCCT) assesses how likely it is that a woman will conceive using assisted reproduction. About 10% of women who are infertile will have an abnormal CCCT. The incidence of an abnormal result increases with age. In one research study using the CCCT, conception only occurred in only 9% of patients with an abnormal CCCT result. This compares to a conception rate of 43% in patients with a normal CCCT result in the same study. (Obstetrics and Gynecology 1993; 82:539-444). In addition you will have an anti-mullerian hormone (AMH) level drawn which has recently also been shown to predict pregnancy potential.
Directions for Doing the Test
The CCCT is considered abnormal if:
Your doctor will interpret and discuss your results with you. There are many factors that can affect the results.
Advanced Reproductive Medicine
Detailed Directions to Our Offices